Get started
Author

Maria Benedetta Giannini

Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters.
2006 · Nicola Vianelli, Maria Benedetta Giannini, et al. · PubMed · 55
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization
2005 · F Palandri, F Bonifazi, et al. · Bone Marrow Transplantation · 44
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia
2015 · Gerardo Musuraca, Serena De Matteis, et al. · Journal of Translational Medicine · 31
PDF
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
2021 · Michele Gottardi, Giorgia Simonetti, et al. · Cancers · 20
PDF
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial
2016 · Andrea Casadei Gardini, Silvia Carloni, et al. · Oncotarget · 20
PDF
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future
2020 · Michele Gottardi, Alessandra Sperotto, et al. · Minerva Medica · 18
Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline
2007 · Marta Stanzani, Fabio Tumietto, et al. · Journal of Medical Microbiology · 17
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia
2020 · Alessandro Cafaro, Maria B. Giannini, et al. · Minerva Medica · 13
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
2021 · Maria Chiara Fontana, Jacopo Nanni, et al. · Biomedicines · 11
PDF
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm
2026 · Naveen Pemmaraju, Giovanni Marconi, et al. · Journal of Clinical Oncology · 10
PDF
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope
2020 · Delia Cangini, Paolo Silimbani, et al. · Minerva Medica · 10
Efficacy and safety of pivekimab sunirine in combination with venetoclax plus azacitidine in unfit patients with newly diagnosed Acute Myeloid Leukemia
2025 · Naval Daver, Anjali Advani, et al. · Blood · 9
PDF
Biological therapy in elderly patients with acute myeloid leukemia
2023 · Giulia Ciotti, Giovanni Marconi, et al. · Expert Opinion on Biological Therapy · 7
PDF
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial
2020 · Claudio Cerchione, Giovanni Martinelli, et al. · Journal of Clinical Medicine · 6
PDF
Prolonged 18FDG‐PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd‐G)
2010 · Gerardo Musuraca, Pier Paolo Fattori, et al. · American Journal of Hematology · 6
PDF
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
2020 · Valentina Giudice, Andrea Ghelli Luserna di Rorà, et al. · International Journal of Molecular Sciences · 5
PDF
Impact of Pre‐Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
2025 · Giovanni Marconi, Elisabetta Petracci, et al. · American Journal of Hematology · 4
PDF
The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia
2021 · Giovanni Marconi, Maria Benedetta Giannini, et al. · Expert Opinion on Drug Safety · 4
Addition of Lenalidomide (LEN) to Azacitidine (AZA) (Combined vs Sequential Treatment) in High-Risk Myelodysplastic Syndromes (MDS): A Randomized Phase II Multicenter Study
2014 · Carlo Finelli, Cristina Clissa, et al. · Blood · 4
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype
2025 · Michela Rondoni, Giovanni Marconi, et al. · Cancers · 3
PDF
INO‐CD22: A multicenter, real‐world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia
2025 · Cristina Papayannidis, Elisabetta Petracci, et al. · Cancer · 3
Romiplostim as Early Treatment of Immune Thrombocytopenia with Severe Immunodeficiency
2012 · Francesca Palandri, Nicola Polverelli, et al. · Hematology Reports · 3
PDF
Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study
2016 · Carlo Finelli, Cristina Clissa, et al. · Blood · 2
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib
2026 · Francesco Angotzi, Erika Borlenghi, et al. · Haematologica · 1
PDF
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort
2026 · Calogero Vetro, Irene Azzali, et al. · Hematological Oncology · 1
PDF
Works count: 56
Citation count: 311
H-index: 10
I10-index: 11
Year
Topic
Type